← Browse by Condition
Medical Condition

her2 low breast carcinoma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT06298084 Phase 1, Phase 2
Recruiting

Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd

Enrollment
152 pts
Location
France
Sponsor
Gustave Roussy, Cancer Campus,...
View Trial →